Fenghua Gao^1*, Hengqi Liu^1*, Xianhuo Wang^1*, Yixin Yao, PhD² and Huilai Zhang^3*

¹Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino-US Center for Lymphoma, Tianjin, China

Efrat Luttwak, MD¹, Annie Qiu^2*, Michelle Okwali, MPH^2*, Alfredo Rivas-Delgado, MD, PhD³, Irem Isgor, MD^4*, Alexander P. Boardman^5*, Philip Caron, MD¹, Kevin A. David, MD^2*, Lorenzo Falchi, MD², Paola Ghione, MD, MSEpi⁶, Paul A. Hamlin, MD², Steven M. Horwitz, MD⁶, Andrew M. Intlekofer, MD, DPhil¹, William Johnson^1*, Anita Kumar, MD⁶, Jennifer Kimberly Lue, MD¹, Alison Moskowitz, MD⁶, Ariela Noy, MD², Pallavi Galera, MBBS⁴, Maria Lia Palomba, MD¹, Robert Stuver, MD¹, Pallawi Torka, MD⁷, Santosha A Vardhana, MD, PhD^2*, Andrew D. Zelenetz, MD, PhD¹, Heiko Schoder, MD^8*, Joachim Yahalom, MD⁹, Ahmet Dogan, MD, PhD¹⁰ and Gilles Salles, MD, PhD²

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Barcelona, Spain
⁴Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York
⁵Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Memorial Sloan Kettering Cancer Center, New York, NY
⁷Lymphoma Service, Department of Medicine, MSKCC, New York, NY
⁸Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York
⁹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY

Yuqin Song, MD¹, Keshu Zhou, MD^2*, Lanfang Li^3*, Aibin Liang, MD, PhD^4*, Yun Qin^5*, Zhen Xia^5*, Yongen Gu^5*, Zisong Zhou^5*, Alex Tian^5* and Jun Zhu, PhD⁶

¹Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China
²Department of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
³Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁴Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China
⁵JW Therapeutics (Shanghai) Co., Ltd., Shanghai, China
⁶Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, Beijing, China

Kurt S. Bantilan, MPH^1* and Andrew D. Zelenetz, MD, PhD²

¹Medicine / Lymphoma, Memorial Sloan Kettering Cancer Center, New York, NY
²Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Nirav N. Shah, MD¹, Pier Luigi Zinzani, MD, PhD², Michael L. Wang, MD³, Sunita D. Nasta, MD⁴, Ewa Lech-Maranda, MD, PhD^5*, Yoshiaki Ogawa, MD, PhD^6*, Bita Fakhri, MD, MPH⁷, Bryone Kuss, MBBS, PhD, FRACP, FRCPA, Fsc⁸, Kaname Miyashita, MD^9*, Krish Patel, MD¹⁰, Catherine C. Coombs, MD¹¹, Shuo Ma, MD, PhD¹², Manish Patel, MD^13*, Minal A. Barve, MD^14*, Benoit Tessoulin^15*, Anastasios Stathis, MD^16*, Won Seog Kim, MD^17*, Daisuke Ennishi, MD, PhD¹⁸, Daigo Hashimoto, MD, PhD¹⁹, Kensuke Kojima, MD, PhD²⁰, Andrew D. Zelenetz, MD, PhD²¹, Jonathon B. Cohen, MD, MS²², Julie M. Vose, MD, MBA²³, Kami J. Maddocks, MD²⁴, Talha Munir, MBBS, MRCP, FRCPath, PhD^25*, Fangfang Sun, MSc^26*, Faith Bian, PhD^26*, Donald E. Tsai, MD, PhD^27*, Paolo Abada, MD²⁷ and Chan Y. Cheah, MD, DMSc²⁸

¹Medical College of Wisconsin, Milwaukee, WI
²Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy
³MD Anderson Cancer Center, Houston, TX
⁴Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA
⁵Institute of Hematology and Transfusion Medicine, Warsaw, Poland
⁶Tokai University School of Medicine, Kanagawa, Japan
⁷Stanford University School of Medicine, Stanford, CA
⁸Flinders Medical Centre and Flinders University, Bedford Park, SA, Australia
⁹National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
¹⁰Swedish Cancer Institute, Seattle, WA
¹¹University of California, Irvine, Irvine, CA
¹²Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
¹³Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, FL
¹⁴Mary Crowley Cancer Research, Dallas, TX
¹⁵Nantes University School of Medicine & University Hospital, Nantes, France
¹⁶Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
¹⁷Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
¹⁸Okayama University Hospital, Okayama, Japan
¹⁹Hokkaido University Hospital, Sapporo, Japan
²⁰Kochi Medical School Hospital, Nankoku, Kochi, Japan
²¹Memorial Sloan Kettering Cancer Center, New York, NY
²²Winship Cancer Institute, Emory University, Atlanta, GA
²³University of Nebraska Medical Center, Omaha, NE
²⁴The Ohio State University Comprehensive Cancer Center, Columbus, OH
²⁵Department of Haematology, St. James's University Hospital, Leeds, United Kingdom
²⁶Eli Lilly and Company, Indianapolis, IN
²⁷Loxo@Lilly, Indianapolis, IN
²⁸Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia

Enrico Tiacci^1*, Luca De Carolis^1*, Monia Capponi^1*, Andrea Bernardelli, MD^1,2*, Andrea Visentin, MD, PhD^3*, Gianna Maria D'Elia^4*, Simone Ferrero, MD⁵, Michele Cimminiello^6*, Azzurra Anna Romeo^7*, Barbara Pocali^8*, Flavio Falcinelli^1*, Alessandro Sanna, MD^9*, Annamaria Frustaci, MD^10*, Nilla Maschio^11*, Caterina Stelitano^12*, Jacopo Olivieri^13*, Carlo Visco^2*, Alessandro Pulsoni, MD^7*, Robin Foa^4*, Livio Trentin¹⁴ and Brunangelo Falini¹

¹Institute of Hematology and Center for Hemato-Oncology Research, University and Hospital of Perugia, Perugia, Italy
²Hematology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
³Hematology unit, Department of Medicine, University of Padova, Padova, Italy
⁴Hematology, University Sapienza and Hospital Umberto I, Rome, Italy
⁵Division of Hematology and Stem Cell Transplant Unit, University Hospital AOU Città della Salute e della Scienza, Torino, Italy
⁶Oncology Department, UOC Hematology and Stem Cell Transplantation, AOR San Carlo, Potenza, Italy
⁷Hematology, University Sapienza, S.M. Goretti Hospital, Latina, Italy
⁸AO di Rilievo Nazionale Antonio Cardarelli, UOC Ematologia con Trapianto di Midollo, Naples, Italy
⁹Hematology, AOU Careggi, Florence, Italy
¹⁰Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
¹¹Onco Hematology, Department of Oncology, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy
¹²Hematology, Hospital of Reggio Calabria, Italy, Reggio Calabria, Italy
¹³Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
¹⁴Hematology Unit, Department of Medicine, University of Padova, Padova, Italy

Nicholas Kendsersky, MD¹, Rebecca Masel, MD², Amman Bhasin, MD^3*, Tingting Zhan, PhD^4*, Carol Gung, NP^5*, Mercy George, CNP^5*, Frederick Michael Fellin, MD^5*, Allison Zibelli, MD^5*, Avnish Bhatia, MD^5*, Rajan Singla^5*, Michael Ramirez, MD^6*, Andrew E. Chapman, DO⁷, Patrick Mille, MD^5*, Cassandra Thomas, MD^8*, Joanne Filicko-O'Hara, MD⁹, Barbara Pro, MD¹⁰, Onder Alpdogan, MD^5*, Adam F. Binder, MD^11,12,13, Pierluigi Porcu, MD¹⁴, Andres Ferber, MD^6,15, Sameh Gaballa^16* and Ubaldo Martinez Outschoorn, MD⁵

¹Thomas Jefferson University Hospital, Philadelphia, PA
²Sidney Kimmel Cancer Center of Thomas Jefferson University #co-first author, Philadelphia, PA
³Thomas Jefferson University, Philadelphia
⁴Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA
⁵Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA
⁶Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia
⁷Sidney Kimmel Cancer at Thomas Jefferson University, Philadelphia, PA
⁸VCMC, Ventura, CA
⁹Bone Marrow Transplant and Cellular Therapy, Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA
¹⁰Lymphoma Program, Division of Hematology & Oncology, Columbia University, New York, NY
¹¹Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA
¹²Department of Medical Oncology, Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center, Philadelphia, PA
¹³Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
¹⁴Sidney Kimmel Cancer Center at Jefferson Health, Thomas Jefferson University, Philadelphia, PA
¹⁵Thomas Jefferson University, Philadelphia, PA
¹⁶H. Lee Moffitt Cancer Center and Research Institute #co-last author, Tampa

Ian W. Flinn, MD, PhD¹, Elizabeth Lihua Elizabeth Budde, MD, PhD², Aung M. Tun, MD³, John M. Burke, MD⁴, Bertrand Anz, MD^5*, Shachar Peles, MD^6*, Jeff P. Sharman, MD⁷, Praveen K. Tumula, MD^8*, Juliana M. L. Biondo, MD⁹, Prachi Jani, MD^9*, Mei Wu, PharmD^9*, Tony Lin, PharmD^9*, Neha Parmar, MD^9*, Yong Mun, PhD^9*, Nai-Shun Yao, MD^9* and Steven Liu, MD^10*

¹Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN
²City of Hope National Medical Center, Duarte, CA
³The University of Kansas Cancer Center, Kansas City, KS
⁴US Oncology Research, Rocky Mountain Cancer Centers, Aurora, CO
⁵Tennessee Oncology, Chattanooga, TN
⁶Florida Cancer Specialists, Atlantis, FL
⁷US Oncology Research, Willamette Valley Cancer Institute and Research Center, Eugene, OR
⁸Texas Oncology-Amarillo Cancer Center, Amarillo, TX
⁹Genentech, Inc., South San Francisco, CA
¹⁰Alaska Oncology & Hematology, Anchorage, AK

Saurabh Zanwar, M.B.B.S., M.D.¹, Jennifer Le-Rademacher, Ph.D.^2*, Eric Durot^3*, Shirley D'Sa^4*, Jithma Prasad Abeykoon, MD⁵, Patrizia Mondello, MD, PhD, MSc⁶, Shaji Kunnathu Kumar, MD⁶, Shayna R Sarosiek⁷, Jonas Paludo, MD⁸, Saurabh Chhabra, MD^9*, Joselle Cook, MBBS⁸, Ricardo Parrondo, MD¹⁰, Angela Dispenzieri, MD⁸, Wilson I. Gonsalves, MD¹¹, Eli Muchtar, MD¹², Sikander Ailawadhi¹³, Robert Kyle, MD¹⁴, Vincent Rajkumar, MD^8*, Alain Jacques Delmer, MD^15*, Rafael Fonseca, MD⁹, Morie A. Gertz, MD¹⁶, Steven P. Treon, MD, PhD, FRCP¹⁷, Stephen M Ansell, MD, PhD⁶, Jorge J. Castillo, MD¹⁸ and Prshant Kapoor, MD¹

¹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
²Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN
³CHU Reims, Reims Cedex, France
⁴Department of Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom
⁵Mayo Clinic, Boston, MN
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
⁸Mayo Clinic, Rochester, MN
⁹Mayo Clinic, Phoenix, AZ
¹⁰Mayo Clinic, Jacksonville, FL
¹¹Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
¹²Mayo Clinic, Rochester, Minnesota, Rochester, MN
¹³Mayo Clinic Florida, Jacksonville, FL
¹⁴Mayo Clinic, Stabile 6-28, Rochester, MN
¹⁵Hôpital Robert Debré CHU de Reims, Reims Cedex, -, FRA
¹⁶Department of Medicine, Division of Hematology,, Mayo Clinic, Rochester, MN
¹⁷Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
¹⁸Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA

Austin I Kim, MD¹, Philippe Armand, MD, PhD², Robert A. Redd, MS^3*, Megan Forsyth^4*, Paul Branch^4*, Samantha Pazienza, BS^4*, Lisa Brennan, RN, BSN^4*, Victoria Patterson, BSN, RN^4*, Susan M Waisgerber, ANP^4*, Reid W. Merryman, MD⁴, David C Fisher, MD⁵, Christine E. Ryan, MD², Inhye E Ahn, MD⁵, Jennifer L Crombie, MD⁶, Oreofe O. Odejide, MD, MPH⁴, Ann LaCasce, MD⁴, Caron A Jacobson, MD, MMSc⁴, Eric Jacobsen, MD⁴, Erin M Parry, MD, PhD⁷, Matthew S. Davids, MD, MMSc⁷, Jennifer R. Brown, MD, PhD², Arnold S. Freedman, MD⁸, Peter A. Riedell, MD⁹ and Mark Alan Murakami, MD, MA, MMSc⁴

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Newton Center, MA
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Dana Farber Cancer Institute, Boston, MA
⁷Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
⁸Dana-Farber Cancer Inst., Boston, MA
⁹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

Alessandra Tedeschi^1*, Chan Yoon Cheah, MD^2,3, Stephen S. Opat, MBBS, FRACP, FRCPA^4,5, Emma Verner^6,7*, Laura Magnano, MD, PhD^8*, Narendranath Epperla, MD, MS⁹, James Hilger^10*, Yiqian Fang^11*, David Simpson^12*, Haiyi Guo^13* and Mary Ann Anderson^14*

¹ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
²Medical School, University of Western Australia, Crawley, Western Australia, Australia
³Department of Haematology, Sir Charles Gairdner Hospital and Pathwest Laboratory Medicine, Nedlands, Western Australia, Australia
⁴School of Clinical Sciences, Monash University, Melbourne, VIC, Australia
⁵Department of Clinical Haematology, Monash Health, Melbourne, VIC, Australia
⁶Concord Repatriation General Hospital, Concord, NSW, Australia
⁷University of Sydney, Sydney, NSW, Australia
⁸Department of Hematology, Hospital Clínic, Barcelona, Barcelona, Spain
⁹The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
¹⁰BeiGene USA, Inc., San Mateo
¹¹BeiGene (Shanghai) Co., Ltd., Shanghai, China
¹²BeiGene USA, Inc, San Mateo, CA
¹³BeiGene (Shanghai) Co., Ltd, Shanghai, China
¹⁴Peter Mac Callum Cancer Centre, Melbourne, VIC, Australia

Yuqin Song, MD¹, Qingqing Cai, PhD^2*, Ming Jiang^3*, Keshu Zhou, MD^4*, Lei Zhang, MD^5*, Xiuhua Sun^6*, Zhengming Jin, B.S.^7*, Lanfang Li^8*, Hongmei Jing⁹, Zhigang Peng, MD^10*, Haiyan Yang¹¹, Junyuan Qi, MD^12*, Hui Zhou^13*, Wei Yang, MD^14*, Min Zhou^15*, Chunyan Ji, md, phd¹⁶, Wei Xu^17*, Kaiyang Ding^18*, Li Yu^19*, Zheng Wang^20*, Nawei Liu^20*, Yejiang Lou^20*, Yue Shen, PhD^20*, Yi Chen, PhD^21*, Fenlai Tan^20* and Jun Zhu^22*

¹Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China
²Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
³The State Key Laboratory of Pathogenesis and Prevention of Central Asian High Incidence Diseases, Urumqi, China
⁴Department of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁵Department of Oncology, The First Affiliated Hospital of Zhengzhou University&Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
⁶The Second Hospital of Dalian Medical University, Dalian, China
⁷Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China
⁸Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁹Peking University Third Hospital, Beijing, China
¹⁰Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
¹¹Zhejiang Cancer Hospital, Hangzhou, China
¹²Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China
¹³Hunan Cancer Hospital, Changsha, China
¹⁴Shengjing Hospital of China Medical University, Shenyang, China
¹⁵Department of Medical Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China
¹⁶Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
¹⁷Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
¹⁸Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Anhui, China
¹⁹The Second Affiliated Hospital of Nanchang University, Nanchang, China
²⁰Guangzhou Lupeng Pharmaceutical Co., Ltd., Guangzhou, China
²¹Newave Pharmaceutical Inc., Pleasanton, CA
²²Department of Lymphoma, Peking University Cancer Hospital and Institute, BEIJING, China

Charles Gaulin, MBBS¹, Preetesh Jain, MD, MBBS, PhD, DM², Ranjit Nair, MD^1,3, Swami P. Iyer, MD², Hun Ju Lee, MD^1*, Luis Fayad, MD⁴, Lei Feng, MS^5*, Yang Liu, PhD^1*, Holly A Hill, MS^6*, Yijing Li, BS, MS^1*, Chi Young Ok, MD⁷, Rashmi Kanagal-Shamanna, MD⁸, Onyeka Oriabure, MSN, RN, NP^6*, Wendy Chen, BS, MPAS, MS^6*, Asiya Siddiqui, MS^2*, Guofan Xu, MBBS, PhD^9*, Anita Deswal, MD, MPH, MBBS^10*, Cezar Iliescu, MD^11*, Maria Badillo^12*, Shaoying Li, MD¹³, Michelle Ky^2*, Michelle Avellaneda^2*, Guilin Tang, MD, PhD^7*, Francisco Vega, MD, PhD¹⁴, Christopher R. Flowers, MD, MS¹ and Michael L. Wang, MD²

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
⁴Lymphoma/Myeloma, M.D. Anderson Cancer Center, Houston, TX
⁵Biostatistics, UT MD Anderson Cancer Center, Houston, TX
⁶Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX
⁹Cardiology, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Geriatrics, MD Anderson Cancer Center, Houston, TX
¹¹Cardiology, The University of Texas MD Anderson Cancer Center, houston, TX
¹²Lymphoma/ Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Department of Hematopathology, MD Anderson Cancer Center , Houston, TX

Gilles Salles, MD, PhD¹, Steven I. Park, MD², Tycel J. Phillips, MD³, Jennifer E. Amengual, MD⁴, David J Andorsky, MD⁵, Philip Campbell, MBBS⁶, Pamela McKay^7*, John P. Leonard⁸, Yingxue Chen^9*, Jade Chen, PhD^9*, Rajat Bannerji, MD, PhD⁹, Apoorva Kapopara, MD, MS^9*, Attila Szanto, MD, PhD^9* and Franck Morschhauser, MD PhD^10,11

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
³City of Hope, Pasadena, CA
⁴Lymphoma Program, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
⁵Rocky Mountain Cancer Centers, Boulder, CO
⁶Andrew Love Cancer Centre, Geelong Hosp., Geelong, VIC, AUS
⁷Haematology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
⁸Weill Cornell Medicine, New York, NY
⁹Ipsen, Cambridge, MA
¹⁰Hematology Department, Centre Hospitalier Régional Universitaire de Lille, Lille, AL, France
¹¹Hôpital Claude Huriez Univ. Lille, CHU Lille, Lille, France

Preetesh Jain, MD, MBBS, PhD, DM¹, Chi Young OK^2*, Loretta J. Nastoupil, MD³, Jason Westin, MD⁴, Holly A Hill, MS^5*, Ranjit Nair, MD⁶, Swami P. Iyer, MD¹, Ahmed Fetooh, MD^7*, Hun Ju Lee, MD^8*, Sairah Ahmed, MD⁹, Rashmi Kanagal-Shamanna, MD¹⁰, Fatima Z Jelloul^11*, Luis Enrique Malpica Castillo, MD¹², Yang Liu, PhD^2*, Yijing Li, BS, MS^8*, Jovanny Vargas^13*, Lei Feng, MS^14*, Maria Badillo^7*, Selvi Thirumurthi, MD^15*, Guofan Xu, MBBS, PhD^16*, Anita Deswal, MD, MPH, MBBS^17*, Cezar Iliescu, MD^18*, Vinh Quang Nguyen, MD^19*, Guilin Tang, MD, PhD^20*, Keyur P. Patel, MBBS, PhD¹¹, Francisco Vega, MD, PhD²¹, L. Jeffrey Medeiros, MD²⁰, Michael L. Wang, MD²² and Christopher R. Flowers, MD, MS⁸

¹Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²The University of Texas MD Anderson Cancer Center, Houston, TX
³MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX
⁵Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
⁷Lymphoma/ Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Hematopathology, MD Anderson Cancer Center, Houston, TX
¹¹Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Department of Lymphoma and Myeloma, University of Texas MD Anderson cancer Center, Houston, TX
¹³Lymphoma Myeloma, The University of Texas MD Anderson Cancer Center, houston, TX
¹⁴Biostatistics, UT MD Anderson Cancer Center, Houston, TX
¹⁵Gastroenterology, The University of Texas MD Anderson Cancer Center, houston, TX
¹⁶Cardiology, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁷Geriatrics, MD Anderson Cancer Center, Houston, TX
¹⁸Cardiology, The University of Texas MD Anderson Cancer Center, houston, TX
¹⁹Geriatrics, The University of Texas MD Anderson Cancer Center, houston, TX
²⁰Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
²¹Department of Hematopathology, MD Anderson Cancer Center , Houston, TX
²²Lymphoma/ Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Neil Berinstein, MD, FRCPC¹, Kim Roos^2*, Kathryn Mangoff^2*, Yidi Jiang^2*, Gail Klein^2*, Rebecca McClure, MD³, Nicholas Forward, MD^4*, Mona Shafey, MD⁵, Anna Nikonova, MD, FRCPC⁶, David MacDonald, MD^7*, Diego Villa, MD⁸, Irwindeep Sandhu, MD^9*, Mohammed Aljama, MBBS, FRCPC^10*, Jean-Francois Larouche, MD¹¹, Monica Gallucci^12* and Heidi Simmons, PhD¹³

¹Sunnybrook Health Sciences, Odette Cancer Centre, Toronto, ON, Canada
²Sunnybrook Research Institute, Toronto, ON, CAN
³Health Sciences North, Sudbury, ON, CAN
⁴Queen Elizabeth II Health Sciences Centre, Halifax, Canada
⁵Tom Baker Cancer Centre and University of Calgary, Calgary, Canada
⁶McGill University Health Centre, Montreal, Canada
⁷Ottawa Health Research Institute, Ottawa, ON, CAN
⁸Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁹Cross Cancer Institute, Edmonton, Canada
¹⁰Juravinski Cancer Centre, Hamilton, ON, CAN
¹¹CHU de Québec – Université Laval, Quebec, QC, CAN
¹²Adaptive Biotechnologies, Seattle
¹³Adaptive Biotechnologies Corporation, Seattle, WA

Yanshan Huang^1,2*, Yuting Yan^2,3*, Ying Yu^3,4*, Li Yuxi, MD^1,4*, Rui Lv^1,4*, Tingyu Wang^5,6*, Wenjie Xiong^3,4*, Qi Wang^3,7*, Wei Liu^4,8*, Gang An^3,4*, Weiwei Sui^3,4*, Yan Xu, MD^3,4*, Wenyang Huang^3,4*, Dehui Zou^4,9*, Lugui Qiu^3,5 and Shuhua Yi^3,4*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, tianjin, China
²Tianjin Institutes of Health Science, Tianjin, China, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁴Tianjin Institutes of Health Science, Tianjin, China, tianjin, China
⁵Tianjin Institutes of Health Science, Tianjin, China
⁶Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sci, Tian Jin, CHN
⁷State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
⁸State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁹Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Xinxin Cao^1*, Jie Jin², Fu Cheng Cheng, MD, PhD^3*, Shuhua Yi^4*, Weili Zhao^5*, Zimin Sun, MD, PhD^6*, Wei Yang^7*, Dengju Li^8*, Guohui CUI^9*, Jianda Hu¹⁰, Ting Liu, MD¹¹, Yongping Song^12*, Bing Xu, MD, PhD^13*, Zunmin Zhu, MD, PhD^14*, Wei Xu^15*, Mingzhi Zhang^16*, Sichen Li^17*, Weige Wang, MD, PhD^18*, Renbin Zhao, PhD^17* and Daobin Zhou, MD^19*

¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
²The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
³The First Affiliated Hospital of Soochow University, Suzhou, China
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁵State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁶Anhui Provincial Hospital, Hefei, China
⁷Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
⁸Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁹Union Hospital, Tongji Medical College,Huazhong University of Science and Technology, WUHAN, CHN
¹⁰Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, Fuzhou, China
¹¹Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China
¹²Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China, Zhengzhou, China
¹³The First Affiliated Hospital of Xiamen University, Xiamen, China
¹⁴Henan Provincial People's Hospital, Zhengzhou, China
¹⁵Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
¹⁶The First Affiliated Hospital of Zhengzhou University and Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan, China
¹⁷InnoCare Pharma Limited, Beijing, China
¹⁸InnoCare Pharma Limited, Shanghai, China
¹⁹Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China

Jacob Soumerai¹, Zaid Yousif^2,3*, Thais Gift^3*, Raj Desai, PhD^4*, Lynn Huynh, DrPH, MBA, MPH^4*, Caitlin Haven^5*, Mei Sheng Duh, RPh, MPH, ScD⁴ and Marie Sanchirico^3*

¹Massachusetts General Hospital Cancer Center: Hematology Oncology, Boston, MA
²University of California San Diego, La Jolla, CA
³Takeda Pharmaceuticals USA, Inc., Lexington, MA
⁴Analysis Group, Inc., Boston, MA
⁵Mass General Brigham, Research Information Science & Computing, Somerville, MA

Jose. C. Villasboas, MD^1*, Tae Min Kim, MD, PhD^2*, Michal Taszner^3*, Silvana Novelli^4*, Seok-Goo Cho^5*, Michele Merli^6*, Ana Jimenez Ubieto^7*, Benoit Tessoulin^8*, Michelle Poon^9*, Jan Walewski^10*, Shuhua Yi^11,12*, Yuqin Song, MD¹³, Geoffrey Chong^14*, Stefano Luminari^15*, Emmanuel Bachy, MD, PhD^16*, Stephanie Guidez^17*, Aranzazu Alonso^18*, Deepa Jagadeesh, MD¹⁹, Wei Zhang^20*, Laura Magnano, MD, PhD^21*, Elżbieta Iskierka-Jażdżewska^22*, Monica Tani^23*, Jessica Cai^24*, Amulya Uppala^24*, Saleem Shariff^25*, Lei Chi^24*, Aafia Chaudhry²⁴, Hesham Mohamed²⁴, Srikanth Ambati^24* and David Tucker^26*

¹Mayo Clinic, Rochester, MN
²Seoul National University Hospital, Seoul, Korea, Republic of (South)
³Medical University of Gdańsk, Gdańsk, Poland
⁴Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
⁵Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁶Ospedale di Circolo e Fondazione Macchi, Varese, Italy
⁷Hospital Universitario 12 de Octubre, Madrid, Spain
⁸Nantes University Hospital, Nantes, France
⁹Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
¹⁰Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warszawa, Poland
¹¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
¹²Tianjin Institutes of Health Science, Tianjin, China
¹³Peking University Cancer Hospital and Institute, Beijing, China
¹⁴Olivia Newton-John Cancer Centre, Heidelberg, VIC, Australia
¹⁵Hematology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy
¹⁶Clinical Hematology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France
¹⁷Hematolgy department, University Hospital of Poitiers, Poitiers, France
¹⁸Hospital Universitario Quiron Salud Madrid, Madrid, Spain
¹⁹Cleveland Clinic, Cleveland, OH
²⁰Peking Union Medical College Hospital, Beijing, China
²¹Department of Hematology, Hospital Clínic, Barcelona, Barcelona, Spain
²²Copernicus Memorial Hospital, Medical University of Łódź, Łódź, Poland
²³Santa Maria delle Croci Hospital, Ravenna, Italy
²⁴Regeneron Pharmaceuticals, Inc., Tarrytown, NY
²⁵Regeneron UK Ltd., Uxbridge, United Kingdom
²⁶Royal Cornwall Hospital, Cornwall, United Kingdom

Diego Villa, MD¹, Jean-Francois Larouche, MD^2*, Matthew C. Cheung, MD, MSc³, Mary-Margaret Keating, MD⁴, Katherine Zukotynski, MD^5*, Petter Tonseth, MD^6*, Samantha Mayo, RN, PhD^7*, Robert Laister, PhD^8*, David W. Scott, MBChB, PhD⁹ and John Kuruvilla, MD, FRCPC¹⁰

¹Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
²Centre Hospitalier Universitaire de Québec, Hôpital de l’Enfant-Jésus, Quebec City, Canada
³Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
⁴Queen Elizabeth II (QEII) Health Sciences Centre, Halifax, NS, CAN
⁵McMaster University, Departments of Radiology and Medicine, Hamilton, Canada
⁶Department of Functional Imaging, BC Cancer, Vancouver, BC, Canada
⁷University of Toronto, Lawrence S. Bloomberg Faculty of Nursing, Toronto, Canada
⁸Princess Margaret Cancer Centre, Toronto, Canada
⁹BC Cancer, Vancouver, BC, Canada
¹⁰Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada

Ramon Garcia-Sanz, MD, PhD^1*, Roger Owen, MD, MRCP, FRCPath^2*, Wojciech Jurczak, MD, PhD^3,4, Meletios A. Dimopoulos, MD, PhD⁵, Helen McCarthy, FRCP, PhD, FRCPath^6*, Gavin Cull, MB, BS, FRACP, FRCPA⁷, Stephen Opat, FRACP, FRCPA, MBBS^8*, Jorge J. Castillo, MD⁹, Marie José Kersten, MD, PhD¹⁰, Björn E. Wahlin, MD, PhD¹¹, Sebastian Grosicki, MD, PhD^12*, Radha Prathikanti, MPH, MBA^13*, Tian Tian, PhD^13*, Heather Allewelt, MD^13*, Aileen Cleary Cohen, MD, PhD¹³ and Constantine S. Tam, MD, MBBS¹⁴

¹Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
²Leeds Teaching Hospitals NHS Trust, Haematological Malignancies Diagnostics Service, Leeds, United Kingdom
³Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
⁴Dpt of Clinical Oncology, MSC National Research Institute of Oncology, Kraków, Poland
⁵Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁶Royal Bournemouth Hospital, Bournemouth, United Kingdom
⁷Sir Charles Gairdner Hospital Hematology Care Centre, Nedlands, WEA, AUS
⁸Monash Health, Clayton, VIC, Australia
⁹Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
¹⁰Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
¹¹Karolinska Universitetssjukhuset Solna, Solna, Sweden
¹²SP ZOZ Zespol Szpitali Miejskich, Chorzow, Poland
¹³BeiGene USA, Inc, San Mateo, CA
¹⁴Alfred Hospital and University of Melbourne, Melbourne, VIC, Australia

Alessandro Mancini^1*, Luca De Carolis^2*, Monia Capponi^2*, Flavio Falcinelli^2*, Edoardo Simonetti^2*, Andrea Lupi^3*, Jacopo Olivieri^4*, Francesco Zaja, MD^5,6*, Matteo Porcari^7*, Nicodemo Baffa^7*, Brunangelo Falini² and Enrico Tiacci^2*

¹Institute of Hematology and Center for Hemato-Oncology Research, University and Hospital of Perugia, PERUGIA, Italy
²Institute of Hematology and Center for Hemato-Oncology Research, University and Hospital of Perugia, Perugia, Italy
³Nuclear Medicine, Hospital S. Bortolo of Vicenza Italy, Vicenza, Italy
⁴Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
⁵DSM, University of Trieste, Trieste, Italy
⁶UCO Ematologia, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy
⁷Nuclear Medicine, Hospital of Perugia, Perugia, Italy

Yazeed Sawalha, MD¹, Shayna R Sarosiek², Rina Li Welkie, MPH¹, Sherif Seif^3*, Shrinjaya Thapa, MD⁴, Saurabh Zanwar, M.B.B.S., M.D.⁵, Kirk Cahill, MD⁶, Rachel Treitman^7*, Haikoo Shah, MD⁸, Shagun Arora, MD⁹, Georgios Pongas, MD¹⁰, Allison Winter, MD¹¹, Ajay Major, MD, MBA¹², Peter A. Riedell, MD⁶, Maria Lia Palomba, MD¹³, Prashant Kapoor, MD⁵, Ariel F. Grajales-Cruz, MD⁴, Kenneth H. Shain, MD, PhD¹⁴, Sheeba K. Thomas, MD¹⁵ and Jorge J. Castillo, MD²

¹The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
²Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
³Department of Lymphoma/Myeloma, UT M.D. Anderson Cancer Center, Houston, TX
⁴H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁵Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁶Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁷University of Colorado School of Medicine, Denver, CO
⁸Cleveland Clinic, Cleveland, OH
⁹UCSF, San Francisco, CA
¹⁰University of Miami, Miami, FL
¹¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹²University of Colorado Cancer Center, Aurora, CO
¹³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
¹⁴H. Lee Moffitt Cancer Center & Research Institute, Saint Petersburg, FL
¹⁵Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Marzia Varettoni^1*, Angela Ferrari^2*, Luigi Marcheselli^3*, Michele Merli^4*, Sara Rattotti, MD^1*, Simone Ferrero, MD⁵, Francesco Merli, MD^2*, Sara Usai, MD^6*, Marina Deodato, MD^7*, Alessandro Pulsoni, MD^8*, Emanuele Cencini, MD^9*, Francesca Re, MD^10*, Carlo Visco^11*, Marcia Torresan Delamain, PhD, MD^12*, Michele Spina, MD^13*, Ombretta Annibali, MD, PhD^14*, Angela Rago^15*, Carola Boccomini, MD^16*, Andrés José María Ferreri, MD¹⁷, Maria Elena Nizzoli^2,18*, Luca Arcaini^1,19* and Stefano Luminari^2*

¹Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²Hematology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy
³Fondazione Italiana Linfomi, Clinical Trial Office, Modena, Italy
⁴Hematology, University Hospital "Ospedale di Circolo e Fondazione Macchi" - ASST Sette Laghi, Varese, Italy
⁵Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy
⁶Ospedale Oncologico Armando Businco, Cagliari, ITA
⁷Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
⁸Hematology, Sapienza University - Polo Pontino, Department of Translational and Precision Medicine, S.M. Goretti Hospital, Latina, Italy
⁹Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy
¹⁰UO Ematologia e CTMO, Azienda Ospedaliera Universitaria di Parma, Parma, Italy
¹¹Hematology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
¹²Hemocentro-Unicamp, University of Campinas, Campinas, AC, BRA
¹³Division of Medical Oncology, IRCCS Centro Di Riferimento Oncologico, Aviano, Italy
¹⁴Hematology and Stem Cell Transplantation Unit, Fondazione Policlinico Universitario Campus Bio medico, Rome, Italy
¹⁵UOSD Ematologia, ASL Roma 1, Roma, Italy
¹⁶Hematology Division, A.O.U Città della Salute e della Scienza di Torino, Torino, Italy
¹⁷Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
¹⁸Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy, Modena, Italy
¹⁹Department of Molecular Medicine, University of Pavia and Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Carrie I Ho, MD^1,2, David Wu, MD, PhD^3*, Qian Wu^1*, Kevin Ng, M.S.^1*, Jenna M Voutsinas, MPH^1*, Ryan C Lynch, MD^1,2, Manoj P Menon, MD^1,2*, Christina Poh, MD^1,2, Mazyar Shadman, MD^1,2, Brian G Till^1,2, Chaitra S Ujjani, MD^1,2, Ajay K Gopal, MD^1,2 and Stephen D Smith, MD^1,2

¹Fred Hutchinson Cancer Center, Seattle, WA
²Division of Hematology and Oncology, University of Washington, Seattle, WA
³Hematopathology, University of Washington, Seattle, WA

Jie Zha^1,2*, Qinwei Chen^2,3*, Wei Zhang^4*, Hongmei Jing, MD⁵, Jingjing Ye^6*, Haifeng Yu^7,8*, Shuhua Yi^9*, Caixia Li^10*, Zhong Zheng^11*, Wei Xu^12*, Zhifeng Li^13*, Lingyan Ping^14*, Xiaohua He^15,16,17*, Liling Zhang^18*, Ying Xie^19*, Feili Chen^20*, Xiuhua Sun^21*, Liping Su^22*, Huilai Zhang, MD^23*, Zhijuan Lin^3,24*, Haiyan Yang²⁵, Weili Zhao²⁶, Lugui Qiu⁹, Zhiming Li^16,17,27*, Yuqin Song, MD²⁸ and Bing Xu^2,3*

¹Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, xiamen, China
²Key laboratory of Xiamen for diagnosis and treatment of hematological malignancy, Xiamen, China
³Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China
⁴Department of Hematology, Peking Union Medical College Hospital, Beijing, China, Beijing, China
⁵Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China
⁶Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
⁷Department of Lymphoma, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
⁸Department of Lymphoma, Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China
⁹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
¹⁰National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
¹¹Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, shanghai, China
¹²Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
¹³Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, Xiamen, China
¹⁴Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China
¹⁵Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
¹⁶State Key Laboratory of Oncology in South China, Guangzhou, China
¹⁷Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
¹⁸Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
¹⁹Shengli Clinical Medical College of Fujian Medical University, Department of Hematology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China
²⁰Lymphoma division, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
²¹The Second Hospital of Dalian Medical University, Dalian, China
²²Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China
²³Department of Lymphoma, Tianjin Medical University Cancer Hospital, Tianjin, China
²⁴Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen,, Xiamen, China
²⁵Zhejiang Cancer Hospital, Hangzhou, China
²⁶Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
²⁷Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
²⁸Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China

Ping Yang^*, Shuozi Liu^*, Weilong Zhang^*, Jing Wang^*, Yingtong Chen^* and Hongmei Jing, MD

Peking University Third Hospital, Beijing, China

Ahmad Ghorab, MD, MSc¹, Firas Baidoun, MD¹, Osama Mosalem, M.D.^2*, Karan Seegobin, MBBS³, Muhamad Alhaj Moustafa, MD¹ and Han Tun, MD¹

¹Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
²Department of Oncology, Mayo clinic Florida, Jacksonville, FL
³Department of Medical Oncology, Mayo Clinic Health System, Mankato, MN

Geoff Chong, MD¹, Jodie B Palmer, PhD^2,3*, Allison A Barraclough, BSc, FRACP, FRCPA, MBBS⁴, Leonid Churilov, PhD^5*, Colm Keane, MD⁶, Sze Ting Lee, MBBS, FRACP, FAANMS, PhD^7*, Denise Lee, MBBS, FRCPA, FRACP^8*, Sumita Ratnasingam, MD, FRACP, FRCPA⁹, Charmaine Smith^10* and Eliza A Hawkes, MD^11,12

¹Grampians Health, Ballarat, Australia
²Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia
³School of Cancer Medicine, La Trobe University, Heidelberg, Australia
⁴Haematology Department Fiona Stanley Hospital Murdoch, wa, Australia
⁵University of Melbourne, Parkville, AUS
⁶Frazer Institute, Translational Research Institute, University of Queensland, Brisbane, Australia
⁷Dept Molecular Imaging and Therapeutics, Austin Health, Heidelberg, VIC, Australia
⁸Eastern Health Clinical School, Monash University, Eastern Health, Box Hill, Australia
⁹Barwon Health, Geelong, AUS
¹⁰Austin Health, Heidelberg, AUS
¹¹Department of Clinical Haematology and Medical Oncology, Austin Health, Heidelberg, VIC, Australia
¹²Dept of Haematology & Medical Oncology and Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, Australia

Tycel J. Phillips, MD¹, Matthew Matasar, MD, MS², Toby A. Eyre^3*, Eva Gine, MD⁴, Audrey Filézac De L'Étang, PhD^5*, Ben Byrne, MSc^6*, Linda Lundberg, PhD^5*, Alejandra Padovani, BSc^5*, Christophe Boetsch, PharmD^5*, Alessia Bottos, PhD^5* and Naseer Qayum, MD PhD^6*

¹City of Hope National Medical Center, Duarte, CA
²Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
³Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
⁴Hospital Clínic, Barcelona, Spain
⁵F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁶Roche Products Ltd, Welwyn Garden City, United Kingdom

Lorenzo Falchi, MD¹, Franck Morschhauser, phd², Kim Linton, MD, PhD^3*, Huiqiang Huang, MD, PhD^4*, Faith Galderisi, DO^5*, Syed Quadri, PharmD^5*, Lingmin Zeng, PhD^5*, Daniela Hoehn, MD, PhD^6* and John F. Seymour, MBBS, PhD, FRACP⁷

¹Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Hôpital Claude Huriez, Lille, France
³Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
⁴Sun Yat-sen University, Guangzhou, China
⁵AbbVie, North Chicago, IL
⁶Genmab, Plainsboro, NJ
⁷Peter MacCallum Cancer Centre & the Royal Melbourne Hospital, Melbourne, Australia

Eliza A Hawkes, MD¹, Rachel Fletcher^2*, Andrew Wood^2*, Stefanie Meyer^3*, Simon Rule, MD^4*, Jingyang Zhang^5* and Michael L. Wang, MD⁶

¹Olivia Newton John Cancer Research & Wellness Centre, Austin Health, Heidelberg, Australia
²AstraZeneca, Cambridge, United Kingdom
³AstraZeneca, Waltham, MA
⁴AstraZeneca, Mississauga, ON, Canada
⁵AstraZeneca, South San Francisco, CA
⁶The University of Texas MD Anderson Cancer Center, Houston, TX

Catherine Thieblemont, MD^1*, Annarita Conconi, MD^2*, Christian Buske, MD³, Stefano Luminari, MD⁴, Martin Dreyling, MD⁵, Maria Gomes da Silva, MD^6*, Marc Andre, MD^7*, Maria Flores^8,9*, Karima Brahami-Aissou^10*, Pascale Cony-Makhoul, MD^11* and Sylvain Carras^12*

¹Assistance Publique Des Hopitaux De Paris, Paris, FRA
²SSD Ematologia, Nuovo Ospedale degli Infermi, Biella, Italy
³Comprehensive Cancer Center Ulm, University Hospital Ulm, Ulm, Germany
⁴Department of Diagnostic, Clinical, and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
⁵Department of Medicine, Medical Clinic III, Ludwig-Maximilians-University Hospital, Munich, Germany
⁶Hematologia, Instituto Português de Oncologia de Lisboa, Lisboa, Portugal
⁷Department of Hematology, Clinique de Mont-Godinne, Yvoir, Belgium
⁸LYSARC, Lyon, France
⁹Lymphoma Academic Research Organisation, Pierre Bénite, France
¹⁰Lymphoma Academic Research Organisation, Pierre-Bénite, France
¹¹Lymphoma Academic Research Organisation (LYSARC), Pierre-Bénite, France
¹²Hematology, Univ. Grenoble Alpes. Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309), University Hospital, La Tronche, France